本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immatics N.V.

10.18
+0.34003.46%
盘后10.02-0.1600-1.57%17:38 EST
成交量:41.49万
成交额:418.62万
市值:13.65亿
市盈率:-9.07
高:10.31
开:9.95
低:9.56
收:9.84
52周最高:12.41
52周最低:3.30
股本:1.34亿
流通股本:6,252.40万
量比:1.08
换手率:0.66%
股息:- -
股息率:- -
每股收益(TTM):-1.1224
每股收益(LYR):0.1449
净资产收益率:-30.03%
总资产收益率:-16.22%
市净率:2.82
市盈率(LYR):70.23

数据加载中...

公司资料

公司名字:
Immatics N.V.
交易所:
NASDAQ
成立时间:
- -
员工人数:
645
公司地址:
Paul-Ehrlich-Strasse 15,Tübingen,Baden-Württemberg,Germany
邮编:
72076
传真:
49 7071 5397 900
简介:
Immatics N.V.于2020年3月10日成立,是一家荷兰私人有限责任公司。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。

董事

名称
职位
Harpreet Singh
Executive Director and Chief Executive Officer
Peter Chambré
Chairman
Adam Stone
Non-executive director
Eliot Forster
Non-executive director
Heather L. Mason
Non-executive director
Mathias Hothum
Non-executive director
Michael G. Atieh
Non-executive director
Paul R. Carter
Non-executive director
Alise Reicin
Director

股东

名称
职位
Harpreet Singh
Executive Director and Chief Executive Officer
Venkat Ramanan
Chief Financial Officer
Carsten Reinhardt
Chief Development Officer
Cedrik Britten
Chief Medical Officer
Edward Sturchio
General Counsel
Jordan Silverstein
Head of Strategy
Rainer Kramer
Chief Business Officer
Steffen Walter
Chief Operations Officer
Toni Weinschenk
Chief Innovation Officer